Selarsdi™ ,
Ustekinumab-aekn
Disease
Crohn's disease
,
Ulcerative colitis
,
Drug Class
Biologics/Biosimilars
Delivery Method
IV
or
Injection
or
Brand name:
Selarsdi™
(This drug is a biosimilar to Stelara®)
,Drug name:
Ustekinumab-aekn
Drug type
Interleukin-12 and -23 Antagonist
Recommendations for pregnancy
Limited human data; No adverse effects or risks in animal studies
Recommendations for breastfeeding
No human data
Most common side effects
Common side effects include upper respiratory infections, headache, tiredness, itching, vomiting, vaginal yeast infections, urinary tract infections, redness at the injection site
Other
Rare side effects include reversible posterior leukoencephalopathy syndrome (this is a reversible syndrome that can include headache, altered mental functioning, seizures, and loss of vision).
Learn more about
Biologics/Biosimilars